Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy a randomized trial
- Gregory J. Dore*
- , Frederick Altice
- , Alain H. Litwin
- , Olav Dalgard
- , Edward J. Gane
- , Oren Shibolet
- , Anne Luetkemeyer
- , Ronald Nahass
- , Cheng Yuan Peng
- , Brian Conway
- , Jason Grebely
- , Anita Y.M. Howe
- , Isaias N. Gendrano
- , Erluo Chen
- , Hsueh Cheng Huang
- , Frank J. Dutko
- , David C. Nickle
- , Bach Yen Nguyen
- , Janice Wahl
- , Eliav Barr
*Corresponding author for this work
- University of New South Wales
- Yale University
- Albert Einstein College of Medicine
- University of Oslo
- Auckland Clinical Studies
- Tel Aviv Sourasky Medical Center
- University of California at San Francisco
- ID Care
- China Medical University Taichung
- Vancouver Infectious Diseases Centre
- Providence Health Care Canada
- Merck
Research output: Contribution to journal › Article › peer-review
335
Scopus
citations